 |
DNA plasmid expressing diphtheria toxin triggered by the presence of oncofetal gen H19 |
|---|---|
| Trade Name | |
| Orphan Indication | Ovarian cancer |
| USA Market Approval | USA |
| USA Designation Date | 2009-08-20 00:00:00 |
| Sponsor | BioCancell Therapeutics US, Inc.;1 Kendall Square, Building 1400, Suite 14303;Cambridge, Massachusetts, 02139 |
